Volume 8, Issue 1 (6-2021)                   vacres 2021, 8(1): 104-109 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Alamdary A, Gholami A, Azizi M, Noormohammadi Z. Construction and Rescue of a Rabies Virus with Duplicated Glycoprotein Gene. vacres. 2021; 8 (1) :104-109
URL: http://vacres.pasteur.ac.ir/article-1-280-en.html
Viral Vaccines Production Unit, Pasteur Institute of Iran Production and Research Complex, Karaj, Iran.
Abstract:   (334 Views)
Introduction: Rabies is almost always fatal but entirely preventable through proper vaccination. Inadequacy of costly high-quality cell culture vaccines is sometimes a bottleneck for expanded rabies control plans. Reverse genetics along with other molecular biology means are trying to improve the immunogenicity and yield of rabies vaccine products. Methods: An additional glycoprotein gene of the rabies virus PV strain was inserted between the glycoprotein and polymerase genes of the virus. The viral proteins were expressed at the T7BHK cell line to rescue the recombinant virus. Results: The recombinant virus containing two consecutive glycoprotein genes was rescued from T7BHK cells. The virus particles were functional and successfully infected the permissive BSR cell line. Conclusion: The new virus strain with an additive copy of the glycoprotein gene has a good potential to be utilized in different studies, including cell biology and immunological properties of the rabies virus. In this study, the recombinant rabies virus was successfully rescued from cell culture which would pave the way for further investigations on this virus.
Full-Text [PDF 505 kb]   (108 Downloads)    
Type of Study: Original article | Subject: Vaccine development, efficacy and safety evaluation
Received: 2022/04/3

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.